Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GH Guardant Health Inc.

Trading 11-04 12:44:57 EST

169.29

-5.71

-3.26%

High177.77	Low167.25	Vol912.23K
Open176.49	D1 Closing175.00	Amplitude6.01%
Mkt Cap22.72B	Tradable Cap21.97B	Total Shares134.20M
T/O154.92M	T/O Rate0.70%	Tradable Shares129.78M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":169.29,"timestamp":1793814295641,"preClose":175,"halted":0,"volume":912229,"delay":0,"changeRate":-0.03262857142857147,"floatShares":129778058,"shares":134196170,"eps":-3.503749,"marketStatus":"Trading","change":-5.71,"latestTime":"11-04 12:44:57 EST","open":176.49,"high":177.77,"low":167.25,"amount":154923349.34405002,"amplitude":0.060114,"askPrice":169.28,"askSize":300,"bidPrice":169.15,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-3.503749,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793826000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":175,"preHourTrading":{"tag":"盘前","latestPrice":179.5,"preClose":175,"latestTime":"09:19 EST","volume":71,"amount":12587.3699,"timestamp":1793801984815,"change":4.5,"changeRate":0.025714,"amplitude":0.051429},"postHourTrading":{"tag":"盘后","latestPrice":171.6,"preClose":175,"latestTime":"19:44 EST","volume":149031,"amount":25643344.7356,"timestamp":1793753046014,"change":-3.4,"changeRate":-0.019429,"amplitude":0.047771},"volumeRatio":0.979945,"impliedVol":0.8122,"impliedVolPercentile":0.9801},"requestUrl":"/m/hq/s/GH","defaultTab":"news","newsList":[{"id":"1119275551","title":"Earning Preview: Guardant Health Inc. revenue is expected to increase by 48.65%, institutional views are cautiously bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1119275551","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1119275551?lang=en_us&edition=fundamental","pubTime":"2026-10-29 17:35","pubTimestamp":1793266507,"startTime":"0","endTime":"0","summary":"Abstract Guardant Health Inc. will report third-quarter results on November 05, 2026 Post-Mkt; this preview summarizes last quarter’s actuals, this quarter’s sell-side and company-level forecasts,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Guardant Health Inc. revenue is expected to increase by 48.65%, institutional views are cautiously bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680703635","title":"Guardant Health Appoints Former Dexcom CEO Kevin Sayer to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2680703635","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680703635?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:02","pubTimestamp":1793743357,"startTime":"0","endTime":"0","summary":"Guardant Health Appoints Former Dexcom CEO Kevin Sayer to BoardGuardant Health appointed Kevin Sayer to its board. Sayer served as Dexcom CEO from 2015 to 2026.Disclaimer:This news brief was created b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDLcbzkMh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BMPRXR70.SGD","BK4504","GDOC","LU2210150020.SGD","LU0354030438.USD","LU0109394709.USD","EKG","LU1923622614.USD","LU2125909593.SGD","LU0354030511.USD","FFOX","GB00BDT5M118.USD","LU1323610961.USD","BK4082","LFSC","BK4585","HEAL","BK4196","IE00BMPRXN33.USD","LU2210149790.SGD","GNOM","LU2095319765.USD","PTH","DXCM","BK4548","LU0889565916.HKD","GH","BK4535","LU2125909247.SGD","LU2433249047.HKD","LU2324357040.USD","BK4534","BK4551","HELX","LU0320765992.SGD","LU0266013472.USD","GNMX","LU2211815571.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680770405","title":"Kevin Sayer Joins Guardant Health Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2680770405","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680770405?lang=en_us&edition=fundamental","pubTime":"2026-11-04 05:30","pubTimestamp":1793741401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nTUAVR3JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","PTH","BK4588","LFSC","BK4196","LU0320765992.SGD","EKG","GDOC","GNMX","BK4551","LU0109394709.USD","GH","GNOM","FFOX","BK4585","HELX","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680970553","title":"Guardant Health (GH) Heads To ESMO, Is The Premium Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2680970553","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680970553?lang=en_us&edition=fundamental","pubTime":"2026-11-04 05:28","pubTimestamp":1793741320,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) is back in front of oncologists, with multiple presentations scheduled at the 2026 European Society for Medical Oncology Congress in Spain. That conference spotlight prompts a closer look at the stock today.\nGuardant Health’s share price has cooled in the very short term, with a 1-day share price return of 4.51% down and a 30-day share price return of 3.98% down, yet the year-to-date share price return of 67.81% and a 1-year total shareholder return of 72.59% indicate...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-heads-to-esmo-is-the-premium-already-pric","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-heads-to-esmo-is-the-premium-already-pric","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","LU0109394709.USD","GDOC","GNMX","LU0320765992.SGD","BK4551","PTH","BK4588","BK4535","LU0889565916.HKD","BK4585","GNOM","HELX","FFOX","EKG","LFSC","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680672172","title":"Guardant Health Grants Co-CEOs 465,413 Performance-Based Stock Units Each at Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2680672172","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680672172?lang=en_us&edition=fundamental","pubTime":"2026-11-03 21:20","pubTimestamp":1793712013,"startTime":"0","endTime":"0","summary":"Guardant Health Grants Co-CEOs 465,413 Performance-Based Stock Units Each at TargetGuardant Health granted co-CEOs Helmy Eltoukhy and AmirAli Talasaz 465,413 target performance-based restricted stock ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL9Fbs5q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","HELX","PTH","BK4585","BK4535","GH","BK4588","GNMX","LFSC","GDOC","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","EKG","BK4551","BK4196","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102348837","title":"Movement Alert｜Guardant Health Inc. Falls 5.08% in Regular Trading, patent litigation overhang weighs on sentiment ahead of earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1102348837","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102348837?lang=en_us&edition=fundamental","pubTime":"2026-11-02 23:55","pubTimestamp":1793634942,"startTime":"0","endTime":"0","summary":"On November 2, Guardant Health Inc. fell 5.08% in Regular Trading, trading at $169.9025, with turnover of $55.722 million.The clearest catalyst was continued pressure from a patent litigation setback...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Guardant Health Slides on Patent Setback Ahead of Earnings","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680272362","title":"Should Expanded Screening Coverage Require Action From Guardant Health Stock Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2680272362","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680272362?lang=en_us&edition=fundamental","pubTime":"2026-11-01 05:28","pubTimestamp":1793482116,"startTime":"0","endTime":"0","summary":"Guardant Health recently highlighted two key developments: anticipated Q3 2026 results with higher earnings on stronger revenue, and a new Pennsylvania law that aligns colorectal cancer screening coverage with current guidelines for roughly 2 million eligible residents.\nThe Pennsylvania legislation, which takes effect on December 21, 2026, could broaden access to Guardant Health’s Shield blood test by removing cost sharing for many commercially insured adults, directly affecting test demand,...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/should-expanded-screening-coverage-require-action-from-guard","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/should-expanded-screening-coverage-require-action-from-guard","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","BK4588","BK4551","LU0889565916.HKD","PTH","LU0109394709.USD","ISBC","GH","LU0320765992.SGD","LFSC","BK4196","GNMX","BK4535","GNOM","GDOC","BK4585","FFOX","EKG","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161272526","title":"Movement Alert｜Guardant Health Inc. Falls 5.26% in Regular Trading, Patent Challenge Rejection Revives Litigation Overhang","url":"https://stock-news.laohu8.com/highlight/detail?id=1161272526","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161272526?lang=en_us&edition=fundamental","pubTime":"2026-10-31 02:39","pubTimestamp":1793385592,"startTime":"0","endTime":"0","summary":"On October 31, Guardant Health Inc. fell 5.26% in Regular Trading, trading at $176.28/share, with turnover of $137 million.The clearest recent catalyst is a patent ruling: an appeal board rejected...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Guardant Health Drops as Patent Challenge Rejection Revives Litigation","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679407944","title":"Guardant Health ‘applauded’ new law in PA for colorectal cancer screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2679407944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679407944?lang=en_us&edition=fundamental","pubTime":"2026-10-29 20:27","pubTimestamp":1793276843,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) “applauded” the enactment of a new law in Pennsylvania, PA, aligning insurance coverage for colorectal cancer screening to ref...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-applauded-new-law-in-pa-for-colorectal-cancer-screening-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-applauded-new-law-in-pa-for-colorectal-cancer-screening-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EKG","BK4588","LU0889565916.HKD","BK4585","LU0320765992.SGD","GNOM","GNMX","HELX","BK4551","FFOX","LFSC","LU0109394709.USD","BK4535","PTH","BK4196","GDOC","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679840493","title":"Guardant Health Welcomes Pennsylvania Law Expanding Colorectal Cancer Screening Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2679840493","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679840493?lang=en_us&edition=fundamental","pubTime":"2026-10-29 20:13","pubTimestamp":1793276026,"startTime":"0","endTime":"0","summary":"Guardant Health Welcomes Pennsylvania Law Expanding Colorectal Cancer Screening CoverageGuardant Health welcomed Pennsylvania's HB 1123, expanding access to colorectal cancer screening options includi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nNDLRpzPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","LFSC","LU0320765992.SGD","GNOM","HELX","GNMX","LU0109394709.USD","BK4535","PTH","BK4588","GH","EKG","LU0889565916.HKD","BK4196","BK4551","GDOC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678760179","title":"Guardant Health price target raised to $210 from $195 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2678760179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678760179?lang=en_us&edition=fundamental","pubTime":"2026-10-27 19:20","pubTimestamp":1793100040,"startTime":"0","endTime":"0","summary":"BTIG analyst Mark Massaro raised the firm’s price target on Guardant Health (GH) to $210 from $195 and keeps a Buy rating on the shares as part of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-210-from-195-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-210-from-195-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","GDOC","GNMX","BK4535","LFSC","PTH","BK4196","LU0320765992.SGD","EKG","LU0109394709.USD","BK4551","HELX","BK4585","BK4588","GH","LU0889565916.HKD","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678480118","title":"Guardant Health (GH) Stock Looks Rich Even With Cash Flow Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2678480118","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678480118?lang=en_us&edition=fundamental","pubTime":"2026-10-27 01:29","pubTimestamp":1793035747,"startTime":"0","endTime":"0","summary":"Guardant Health has delivered a very large 3 year share price gain, which puts fresh attention on whether the current market value lines up with the cash flows the business can realistically produce. With both legal setbacks and product milestones in the spotlight, the key issue for investors is how those events feed into that cash flow picture.\n\nOver the past 3 years the stock has returned about 5.7x, which makes the pricing of Guardant Health increasingly reliant on what its future cash...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-stock-looks-rich-even-with-cash-flow-upsi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-stock-looks-rich-even-with-cash-flow-upsi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","GNOM","GH","GDOC","PTH","FFOX","BK4585","HELX","LU0889565916.HKD","LU0320765992.SGD","EKG","SPHQ","GNMX","BK4551","BK4535","LFSC","BK4588","DCF","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677299559","title":"Roth Capital Initiates Coverage on Guardant Health With Buy Rating, $200 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2677299559","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677299559?lang=en_us&edition=fundamental","pubTime":"2026-10-23 19:26","pubTimestamp":1792754794,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) has an average rating of buy and mean price target of $198.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4551","BK4588","PTH","GH","BK4196","BK4585","GNMX","HELX","LU0889565916.HKD","GDOC","GNOM","LU0109394709.USD","EKG","BK4535","LFSC","LU0320765992.SGD","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677600549","title":"7 Healthcare Stocks That Stand Out as Investors Pay up for the Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2677600549","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677600549?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:59","pubTimestamp":1792616340,"startTime":"0","endTime":"0","summary":"Investors have pushed the healthcare sector to a record high, and some favored stocks have high projected revenue growth rates through 2028The S&P 500 healthcare sector hit a high this week, as invest","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHI","LU0106261372.USD","ELIL","LU0354030438.USD","LU2602419157.SGD","LU0289961442.SGD","WDNA","LFSC","LU1162221912.USD","LU0353189680.USD","GNOM","LU0006306889.USD","LU1989771016.USD","LU2491049909.HKD","THNR","LU0130102774.USD","LU1929549753.HKD","LU1974910355.USD","LU1093756325.SGD","BK4528","SG9999014914.USD","LU2211815571.USD","SG9999002232.USD","RXL","IE0002270589.USD","LU1267930730.SGD","IE00B7KXQ091.USD","EKG","IE00BKDWB100.SGD","GNMX","LU2265009873.SGD","LU0225283273.USD","BK4501","LU2244417387.USD","XLV","SGXZ23171101.USD","LU0210536198.USD","LU2746668461.USD","LU0477156953.USD","IE0005OL40V9.USD","DXCM","LU2750360997.AUD","LU2087625088.SGD","LU2471134879.HKD","LU1037948541.HKD","LU0048573561.USD","LU0980610538.SGD","IE00BK4W5L77.USD","LU0158827781.USD","LU1571399168.USD","LU0107464264.USD","LU2361044865.SGD","LU0011850046.USD","LU0289739343.SGD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","BK4581","HEAL","LU2168564495.EUR","BK4534","LU1066051498.USD","BK4167","LU2111349929.HKD","LU2462591350.SGD","LU2298321311.HKD","LU1366192091.USD","SG9999014880.SGD","LU1674673428.USD","LU0158827948.USD","LU0096364046.USD","LU0170899867.USD","DHR","LU0823416689.USD","IE00BN8TJ469.HKD","PTH","ISRG","GH","IE0034235188.USD","LU1814569148.SGD","LU0672654240.SGD","LU0203347892.USD","LU0070302665.USD","GB00BDT5M118.USD","LU0417517546.SGD","IE00B1XK9C88.USD","IE00B19Z9Z06.USD","IE00BMPRXR70.SGD","LABU","IE00B4R5TH58.HKD","LU2764263203.CNY","IE00B19Z3581.USD","OZEM","IE00BZ1G4Q59.USD","BK4082","BK4007","BK4121","LGHT","LU1791710400.SGD","LU2023250504.SGD","LU1061106388.HKD","LU0203201768.USD","LU1323610961.USD","LU0466842654.USD","IBBQ","LU2750360641.GBP","GRAL","LU1934455863.HKD","IE00BJT1NW94.SGD","LU0342679015.USD","LU0238689110.USD","BK4613","IBB","LU2125909759.SGD","IE00BQXX3C00.GBP","IE00B19Z8W00.USD","LU0251131958.USD","LU0820562030.AUD","LU0320765059.SGD","LU0124676726.USD","LU0965509283.SGD","LU1066051811.HKD","LU0787776722.HKD","LU1854103824.USD","LU2125910336.SGD","LU2168564149.EUR","LU0320765489.SGD","LU2404859741.USD","LU1623119135.USD","LU1917777945.USD","LU0133085943.USD","LU1923622614.USD","SGXZ81514606.USD","LU1236620834.HKD","LU0203202063.USD","IE0002141913.USD","LU0256863811.USD","LU0072461881.USD","LU1035773651.USD","LU0345770308.USD","LU0943347566.SGD","LU2063271972.USD","LU2168563687.JPY","LU0861579265.USD","IE00BYQQ9H92.USD","LU2756315664.SGD","LU2433249047.HKD","PAWZ","MHIP","LU0316494557.USD","LU2746668974.SGD","TBXU","LU0640476718.USD","LU0251142724.SGD","MRNX","IE00BJLML261.HKD","LU0057025933.USD","BK4566","LU1119994496.HKD","SG9999015952.SGD","LU1934455277.USD","LU2461242641.AUD","LLYX","LU1868837136.USD","LU0312595415.SGD","LU2065170008.USD","IE00BKPKM429.USD","BBH","LU0472753341.HKD","LU0471298694.HKD","LU1280957306.USD","LU0456855351.SGD","BK4196","IYH","IE00B1BXHZ80.USD","LU1854104046.USD","LU1145028129.USD","LU1778281490.HKD","LU0058720904.USD","BMED","JDOC","IE00BJJMRY28.SGD","BLLN","LU0528227936.USD","SG9999013999.USD","LU1951198990.SGD","LU2089283258.USD","LU0130517989.USD","LU2491050071.SGD","LU2237443382.USD","LU0211331839.USD","IE000M9KFDE8.USD","LU0786609619.USD","SGXZ51526630.SGD","BK4585","SG9999004303.SGD","LU2237443978.SGD","LU2462157665.USD","LU2125910179.SGD","LU2360106947.USD","LU2552382215.SGD","PODD","IE00BZ9MQY76.HKD","LU1366333091.USD","IE00B19Z9505.USD","LU0289739699.SGD","TRUH","LU2237443895.HKD","LU2357627491.SGD","LU2237443622.USD","CANC","LU1988902786.USD","IE00BLSP4452.SGD","SG9999014575.USD","LU2360032135.SGD","LU1923622291.USD","MRNA","LU2168564222.USD","LU0162691827.USD","LU0432979614.USD","LU2764262908.HKD","LU2125909593.SGD","SG9999014567.USD","LU1066051225.USD","LU2552382058.USD","LU1069344957.HKD","BK4588","LU2468319806.SGD","LU2211817866.USD","LU1989764664.SGD","LU2023250843.SGD","IE00BWXC8680.SGD","LU2023251221.USD","LU2108987350.USD","LU0882574139.USD","LU2361045086.USD","LU2125909247.SGD","LU2237443549.SGD","LU0198837287.USD","IE00B5TLWC47.USD","SGXZ31699556.SGD","LU0965509101.SGD","SGXZ57979304.SGD","BK4550","LU2552382132.HKD","LU2092937221.SGD","LU0187121727.USD","LU1548497426.USD","LU2065171402.SGD","LU2362541273.HKD","LU1551013425.SGD","VEEV","IE00BN29S564.USD","IE00BFSS7M15.SGD","LU0708995401.HKD","SG9999017495.SGD","LU1093756168.USD","LU2210149790.SGD","LU1983299246.USD","VRTX","ELIS","LU0353189763.USD","LU0097036916.USD","LU0390134368.USD","BK4516","LU2357305700.SGD","IE00BJJMRZ35.SGD","GDOC","LU0256863902.USD","SG9999014898.SGD","IE00B4JS1V06.HKD","LU0310800379.SGD","LU1934455194.USD","LU2543165471.USD","LU1127390331.HKD","BK4535","IE0009355771.USD","LU0820561909.HKD","LU1670627923.USD","LU2404859667.USD","IE00BQXX3F31.USD","HRTS","LU0690374961.EUR","SG9999018865.SGD","IE00BSNM7G36.USD","XBI","LU2125154778.USD","LU0265550359.USD","IE00B19Z9P08.USD","LU1551013342.USD","LU1069347547.HKD","LU1691799644.USD","LU0345770993.USD","LU0683600562.USD","SG9999014906.USD","LU2456880835.USD","SG9999001176.SGD","LU1153585028.USD","LU2355687059.USD","LU0174119429.USD","LU2361044949.HKD","ISUL","LU1430594728.SGD","LU2896262040.SGD","IE00B894F039.SGD","LU0265550946.USD","SG9999014542.SGD","LU2271345857.HKD","LU0648001328.SGD","ILDR","BK4533","LU0109394709.USD","LU0823434583.USD","IE00B775H168.HKD","IE0004445015.USD","LU1291159041.SGD","BIB","LU1989764748.USD","TMED","LU2471134523.USD","LLYZ","LU0728928796.USD","LU1064131342.USD","LU1585245621.USD","LU1023059063.AUD","LU2236285917.USD","LU1633808545.USD","TMO","IHE","SG9999015341.SGD","LU1951200564.SGD","IE00BMPRXN33.USD","LU0122379950.USD","LU1923623000.USD","IE0004445239.USD","LU2089284900.SGD","LU1979441026.SGD","LU1074936037.SGD","LU2362541513.USD","LU2211814178.USD","LU0742534661.SGD","AGNG","IE0001KFT4U8.USD","BK4568","IE00BFTCPJ56.SGD","LU1868837300.USD","LU0175139822.USD","LU1201861249.SGD","LU2028103732.USD","BK4532","LLY","LU1057294990.SGD","LU1989772923.USD","LU0069063385.USD","LU2764263039.SGD","IE00BJJMRX11.SGD","MRK","SG9999015978.USD","LU2089984988.USD","LU0079474960.USD","FFOX","IE00BQXX3D17.EUR","LU1629891620.HKD","LU1037948897.HKD","SG9999001176.USD","LU2213496289.HKD","BK4567","FMED","LU0708994859.HKD","LU2023250330.USD","LU2756315318.SGD","LU0868494617.USD","BK4548","SG9999014559.SGD","LU2491050154.USD","LU1699723380.USD","LU1868836914.USD","GB00B4QBRK32.GBP","LU0234570918.USD","LU0690374615.EUR","LU1261432733.SGD","SGXZ99366536.SGD","LU2360108059.USD","LU0985320562.USD","LU0029864427.USD","SG9999015358.SGD","LU0511384066.AUD","LU2720916845.USD","LU2106854487.HKD","LU0320765992.SGD","LU0957791311.USD","SG9999015986.USD","HELX","BK4139","LU2168564065.EUR","LU0820561818.USD","FHLC","IE00B2B36J28.USD","IE00BK4W5M84.HKD","LU0889565916.HKD","LU2471134952.CNY","BK4551","LU0323591593.USD","LU0965509010.AUD","LU1720051108.HKD","LU0061474960.USD","IE00BFXG0V08.USD","LU0964807845.USD","PBE","LU1791710582.SGD","LU0094547139.USD","LU0203345920.USD","LU1941712264.USD","LU1032466523.USD","LU0128525929.USD","LU1923621640.USD","SG9999001440.SGD","MEDI","LU2125909916.SGD","LU2362540622.SGD","LU0868494708.USD","LU1236620750.USD","LU0109391861.USD","PPH","IE00BBT3K403.USD","LU1941712348.USD","LU0965508806.USD","LU0320765646.SGD","MRNY","LU0689472784.USD","LU0061475181.USD","LU1670628061.USD","MEDX","LU1989772840.SGD","LU2324357040.USD","LU1116320901.HKD","BK4559","LU1035775433.USD","LU0234572021.USD","BK4504","LU0385154629.USD","LU1804176565.USD","LU2471134796.USD","LU2417539215.USD","LU1084165304.USD","LU2237443465.HKD","LU1868836757.USD","LU0859254822.USD","LU1868836591.USD","LU0096362180.USD","LU1066053197.SGD","BK4599","IE00BFSS8Q28.SGD","FTXH","IDNA","LU1720051017.SGD","CURE","LU0208291251.USD","LU1803068623.USD","LU0882574055.USD","LU1267930573.SGD","LU2095319765.USD","LU2065169927.USD","LU0557290698.USD","IE00BLSP4239.USD","LU0689626769.HKD","SG9999018857.SGD","LU0471298777.SGD","LU2237438978.USD","GB00B4LPDJ14.GBP","SG9999002224.SGD","LU2065171311.SGD","PJP","LU2264538146.SGD","LU1712237335.SGD","LU0114720955.EUR","LU2041044095.USD","LU0289960550.SGD","LU0098860793.USD","LU2112291526.USD","IE00B19Z8X17.USD","LU0157215616.USD","LU2210150020.SGD","LU0942090050.USD","LU1815333072.USD","LU0266013472.USD","LU0354030511.USD","LU1232071149.USD","SG9999015945.SGD","LLII","LU1116320737.USD","LU1674673691.USD","LU0823434740.USD","LU2125154935.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177322113","title":"Movement Alert｜Guardant Health Inc. Intraday Rise 5.01% in Regular Trading, patent challenge rejection highlights ongoing litigation overhang","url":"https://stock-news.laohu8.com/highlight/detail?id=1177322113","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177322113?lang=en_us&edition=fundamental","pubTime":"2026-10-22 02:35","pubTimestamp":1792607736,"startTime":"0","endTime":"0","summary":"On October 22, Guardant Health Inc. rose 5.01% in Regular Trading, trading near $170.785 per share, with turnover of $175 million.The clearest catalyst was a recent patent appeal board decision...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Guardant Health surges as patent challenge rejection upheld","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676247696","title":"Guardant Health to Present 25 Liquid Biopsy Research Abstracts at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2676247696","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676247696?lang=en_us&edition=fundamental","pubTime":"2026-10-20 21:10","pubTimestamp":1792501836,"startTime":"0","endTime":"0","summary":"Guardant Health to Present 25 Liquid Biopsy Research Abstracts at ESMO 2026Guardant Health will present 25 abstracts, including five rapid oral presentations, at ESMO Congress 2026, October 23-27 in M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261020:nNDLG8NxV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","BK4551","GDOC","BK4588","GNMX","BK4535","FFOX","PTH","EKG","GNOM","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","BK4196","GH","BK4585","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676527739","title":"Bernstein Remains a Buy on Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2676527739","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676527739?lang=en_us&edition=fundamental","pubTime":"2026-10-18 21:35","pubTimestamp":1792330519,"startTime":"0","endTime":"0","summary":"In a report released on October 16, Eve Burstein from Bernstein maintained a Buy rating on Guardant Health, with a price target of $210.00. The com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-buy-on-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-buy-on-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GH","FFOX","BK4551","HELX","BK4196","BK4535","LU0320765992.SGD","GDOC","LU0889565916.HKD","LFSC","EKG","GNOM","PTH","LU0109394709.USD","BK4585","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675553359","title":"Guardant Health Director Alex M. Azar II Reports Disposal of $11,032.41 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2675553359","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675553359?lang=en_us&edition=fundamental","pubTime":"2026-10-16 06:03","pubTimestamp":1792101810,"startTime":"0","endTime":"0","summary":"Guardant Health Director Alex M. Azar II Reports Disposal of $11,032.41 in Common SharesGuardant Health director Alex M. Azar II sold 69 shares of common stock on Oct. 14, 2026.The sale price was $159","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nNDL2KF22v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Alex M. Azar II Reports Disposal of $11,032.41 in Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EKG","LU0109394709.USD","LU0320765992.SGD","PTH","BK4588","GNOM","LFSC","FFOX","BK4551","BK4196","GDOC","GH","GNMX","LU0889565916.HKD","BK4585","BK4535","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675053029","title":"Guardant Health's Duplex Sequencing Patent Challenge Rejected by Appeal Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2675053029","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675053029?lang=en_us&edition=fundamental","pubTime":"2026-10-16 04:47","pubTimestamp":1792097241,"startTime":"0","endTime":"0","summary":"Guardant Health's  challenge to all 30 claims of a US patent underlying duplex sequencing and owned by the University of Washington was rejected by the Patent Trial and Appeal Board, TwinStrand Biosciences, the patent's exclusive licensee, said Thursday.The board determined Guardant \"failed to establish the unpatentability\" of any of the challenged claims, TwinStrand said in a statement.The patent is one of two at issue in infringement litigation TwinStrand brought against Guardant in the US District Court for the District of Delaware, according to the statement.The ruling preserved a November 2023 jury verdict that Guardant \"willfully infringed\" the patent and awarded more than $245.2 million in damages, accrued royalties and interest through May 2026, TwinStrand said.Guardant was also directed to pay an ongoing royalty of 6% on all covered products and services through March 2033, TwinStrand said.Guardant did not immediately respond to a request for comment from MT Newswires.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FFOX","LFSC","LU0320765992.SGD","GNOM","HELX","GNMX","LU0109394709.USD","BK4535","PTH","BK4588","GH","EKG","LU0889565916.HKD","BK4196","USRD","BK4551","GDOC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675840005","title":"Guardant presents data from role of blood-based testing in CRC screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2675840005","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675840005?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:21","pubTimestamp":1792066868,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced the company and its research collaborators presented new data showing the critical role of blood-based testing in in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-presents-data-from-role-of-blood-based-testing-in-crc-screening-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-presents-data-from-role-of-blood-based-testing-in-crc-screening-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","GNMX","LU0266512127.USD","LFSC","GNOM","LU0109394709.USD","HELX","FFOX","GH","PTH","BK4551","LU0320765992.SGD","BK4535","BK4585","BK4213","EKG","LU0456854461.SGD","CRC","LU0889565916.HKD","GDOC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":-0.0172},{"period":"1month","weight":-0.0157},{"period":"3month","weight":0.0724},{"period":"6month","weight":0.8968},{"period":"1year","weight":0.7691},{"period":"ytd","weight":0.7133}],"compareEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.0199},{"period":"3month","weight":-0.0201},{"period":"6month","weight":0.0311},{"period":"1year","weight":0.1039},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.071093},{"month":2,"riseRate":0.25,"avgChangeRate":0.034152},{"month":3,"riseRate":0.5,"avgChangeRate":-0.022808},{"month":4,"riseRate":0.375,"avgChangeRate":-0.022604},{"month":5,"riseRate":0.625,"avgChangeRate":0.118443},{"month":6,"riseRate":0.75,"avgChangeRate":0.091261},{"month":7,"riseRate":0.75,"avgChangeRate":0.055},{"month":8,"riseRate":0.5,"avgChangeRate":0.070736},{"month":9,"riseRate":0.375,"avgChangeRate":-0.042394},{"month":10,"riseRate":0.375,"avgChangeRate":0.026879},{"month":11,"riseRate":0.666667,"avgChangeRate":0.113574},{"month":12,"riseRate":0.5,"avgChangeRate":-0.066498}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction